Pilot study of pegylated interferon-alpha 2b in patients with essential thrombocythemia

被引:0
|
作者
Yesid Alvarado
Jorge Cortes
Srdan Verstovsek
Deborah Thomas
Stephan Faderl
Zeev Estrov
Hagop Kantarjian
Francis J. Giles
机构
[1] Department of Leukemia,
[2] The University of Texas M.D. Anderson Cancer Center,undefined
[3] 1515 Holcombe Blvd,undefined
[4] Houston,undefined
[5] Texas 77030,undefined
[6] USA,undefined
来源
关键词
Essential thrombocythemia Pegylated interferon Efficacy;
D O I
暂无
中图分类号
学科分类号
摘要
Abstract
引用
收藏
页码:81 / 86
页数:5
相关论文
共 50 条
  • [31] Differential responsiveness of interferon alpha 2 signaling by pegyiated interferon alpha 2b and pegylated interferon alpha 2a.
    Brassard, D
    Bradshaw, S
    Chapman, JF
    Weiner, S
    DeLorenzo, M
    Bordens, R
    Grace, MJ
    [J]. HEPATOLOGY, 2002, 36 (04) : 548A - 548A
  • [32] Pilot study of tenofovir disoproxil fumarate and pegylated interferon-alpha 2a add-on therapy in Japanese patients with chronic hepatitis B
    Matsumoto, Akihiro
    Nishiguchi, Shuhei
    Enomoto, Hirayuki
    Tanaka, Yasuhito
    Shinkai, Noboru
    Okuse, Chiaki
    Kang, Jong-Hon
    Matsui, Takeshi
    Miyase, Shiho
    Yatsuhashi, Hiroshi
    Nagaoka, Shinya
    Kanda, Tatsuo
    Enomoto, Masaru
    Yamada, Ryoko
    Hiramatsu, Naoki
    Saito, Satoru
    Takaguchi, Koichi
    Ito, Kiyoaki
    Masaki, Tsutomu
    Morihara, Daisuke
    Tsuge, Masataka
    Chayama, Kazuaki
    Ikeda, Fusao
    Kagawa, Tatehiro
    Kondo, Yasuteru
    Murata, Kazumoto
    Tanaka, Eiji
    [J]. JOURNAL OF GASTROENTEROLOGY, 2020, 55 (10) : 977 - 989
  • [33] Pilot study of tenofovir disoproxil fumarate and pegylated interferon-alpha 2a add-on therapy in Japanese patients with chronic hepatitis B
    Akihiro Matsumoto
    Shuhei Nishiguchi
    Hirayuki Enomoto
    Yasuhito Tanaka
    Noboru Shinkai
    Chiaki Okuse
    Jong-Hon Kang
    Takeshi Matsui
    Shiho Miyase
    Hiroshi Yatsuhashi
    Shinya Nagaoka
    Tatsuo Kanda
    Masaru Enomoto
    Ryoko Yamada
    Naoki Hiramatsu
    Satoru Saito
    Koichi Takaguchi
    Kiyoaki Ito
    Tsutomu Masaki
    Daisuke Morihara
    Masataka Tsuge
    Kazuaki Chayama
    Fusao Ikeda
    Tatehiro Kagawa
    Yasuteru Kondo
    Kazumoto Murata
    Eiji Tanaka
    [J]. Journal of Gastroenterology, 2020, 55 : 977 - 989
  • [34] Clinicohematologic and Molecular Response of Essential Thrombocythemia Patients Treated with Pegylated Interferon-Alpha: A Multicenter Study on Behalf of the German Study Group-MPN (GSG-MPN)
    Stegelmann, Frank
    Teichmann, Lino L.
    Heidel, Florian H.
    Crodel, Carl C.
    Ernst, Thomas
    Kreil, Sebastian
    Reiter, Andreas
    Otten, Sara
    Schauer, Stefanie
    Koerber, Ruth-Miriam
    Kricheldorf, Kim
    Isfort, Susanne
    Doehner, Hartmut
    Bruemmendorf, Tim H.
    Griesshammer, Martin
    Doehner, Konstanze
    Koschmieder, Steffen
    [J]. BLOOD, 2022, 140 : 6874 - 6876
  • [35] A phase II study of oral interferon-alpha (IFN-a) for patients with essential thrombocythemia or polycythemia vera.
    Quintas-Cardama, Alfonso
    Giles, Francis
    Cortes, Jorge
    Kantarjian, Hagop
    Verstovsek, Srdan
    [J]. BLOOD, 2006, 108 (11) : 306B - 306B
  • [36] 5-FLUOROURACIL, LEUCOVORIN AND INTERFERON-ALPHA 2B IN ADVANCED PANCREATIC-CANCER - A PILOT-STUDY
    CASCINU, S
    FEDELI, A
    FEDELI, SL
    CATALANO, G
    [J]. ANNALS OF ONCOLOGY, 1993, 4 (01) : 83 - 84
  • [37] High-dose interferon-alpha(2b) treatment prevents chronicity in acute hepatitis C - A pilot study
    Vogel, W
    Graziadei, I
    Umlauft, F
    Datz, C
    Hackl, F
    Allinger, S
    Grunewald, K
    Patsch, J
    [J]. DIGESTIVE DISEASES AND SCIENCES, 1996, 41 (12) : S81 - S85
  • [38] ALPHA-2B INTERFERON AS INDUCTION THERAPY IN ESSENTIAL THROMBOCYTHEMIA
    GILES, FJ
    MACHIN, SJ
    GOLDSTONE, AH
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1988, 69 (01) : 108 - 108
  • [39] RECOMBINANT INTERFERON-ALPHA-2B AS TREATMENT OF ESSENTIAL THROMBOCYTHEMIA
    RAMETTA, V
    FERRARA, F
    MAROTTOLI, V
    MATERA, C
    METTIVIER, V
    CIMINO, R
    [J]. ACTA HAEMATOLOGICA, 1994, 91 (03) : 126 - 129
  • [40] Induction therapy with interferon-alpha 2b associated to Ribavirin and Ketoprofen in patients with chronic hepatitis C non-responders to interferon. A pilot study
    Munoz, AE
    Levi, D
    Miguez, C
    Munne, MS
    Cisterna, D
    Vladimirsky, S
    Gonzalez, J
    Terg, R
    [J]. JOURNAL OF HEPATOLOGY, 2002, 36 : 241 - 241